Literature DB >> 22167380

Adult hypophosphatasia with painful periarticular calcification treated with surgical resection.

Kei-Ichiro Iida1, Jun-Ichi Fukushi, Toshifumi Fujiwara, Yoshinao Oda, Yukihide Iwamoto.   

Abstract

Hypophosphatasia is a rare inherited disorder characterized by a low serum alkaline phosphatase (ALP) activity and defective bone mineralization. Adult hypophosphatasia typically manifests in middle-age as a result of osteomalacia with recurrent stress fractures of the lower limb. However, considerable variation occurs in the clinical expression of hypophosphatasia, and no curative treatment has yet been established. We herein report a case of adult hypophosphatasia with painful calcific periarthritis, which showed improvement after surgical resection. A 32-year-old male was referred to our clinic complaining of pain in his elbows and knees. A painful subcutaneous mass was palpable on his right lateral epicondyle, where periarticular calcification was detected by plain radiography. The laboratory data showed a slight decrease in serum ALP activity and bone mineral density, and an elevation in the urinary phosphoethanolamine. Genomic DNA sequencing revealed an F310L mutation and a Y246H polymorphism in the tissue-nonspecific alkaline phosphatase gene, confirming the diagnosis of hypophosphatasia. The pain in the patient's right elbow was not responsive to nonsteroidal anti-inflammatory drugs, and triamcinolone diacetate was locally injected for treatment. His symptoms were ameliorated after the injection; however, they recurred in 3 months, and he became refractory to additional steroid injection. Surgical debridement of the calcified lesion was performed, and his symptoms were successfully ameliorated after the surgery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22167380     DOI: 10.1007/s00774-011-0338-9

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  16 in total

1.  Hypophosphatasia.

Authors:  D FRASER
Journal:  Am J Med       Date:  1957-05       Impact factor: 4.965

2.  Adult hypophosphatasia. Current aspects.

Authors:  D Wendling; L Jeannin-Louys; P Kremer; F Fellmann; E Toussirot; E Mornet
Journal:  Joint Bone Spine       Date:  2001-03       Impact factor: 4.929

Review 3.  Hypophosphatasia: the mutations in the tissue-nonspecific alkaline phosphatase gene.

Authors:  E Mornet
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

4.  Common mutations F310L and T1559del in the tissue-nonspecific alkaline phosphatase gene are related to distinct phenotypes in Japanese patients with hypophosphatasia.

Authors:  Toshimi Michigami; Takayuki Uchihashi; Akira Suzuki; Kanako Tachikawa; Shigeo Nakajima; Keiichi Ozono
Journal:  Eur J Pediatr       Date:  2005-01-20       Impact factor: 3.183

5.  Correlations of genotype and phenotype in hypophosphatasia.

Authors:  L Zurutuza; F Muller; J F Gibrat; A Taillandier; B Simon-Bouy; J L Serre; E Mornet
Journal:  Hum Mol Genet       Date:  1999-06       Impact factor: 6.150

6.  Gout-associated uric acid crystals activate the NALP3 inflammasome.

Authors:  Fabio Martinon; Virginie Pétrilli; Annick Mayor; Aubry Tardivel; Jürg Tschopp
Journal:  Nature       Date:  2006-01-11       Impact factor: 49.962

7.  Periarthritis associated with basic calcium phosphate crystal deposition and low levels of serum alkaline phosphatase--report of three cases from one family.

Authors:  D Caspi; T O Rosenbach; M Yaron; D J McCarty; E Graff
Journal:  J Rheumatol       Date:  1988       Impact factor: 4.666

8.  Identification of fifteen novel mutations in the tissue-nonspecific alkaline phosphatase (TNSALP) gene in European patients with severe hypophosphatasia.

Authors:  E Mornet; A Taillandier; S Peyramaure; F Kaper; F Muller; R Brenner; P Bussière; P Freisinger; J Godard; M Le Merrer; J F Oury; H Plauchu; R Puddu; J M Rival; A Superti-Furga; R L Touraine; J L Serre; B Simon-Bouy
Journal:  Eur J Hum Genet       Date:  1998 Jul-Aug       Impact factor: 4.246

9.  Pyrophosphate arthropathy in hypophosphatasia.

Authors:  A W Eade; A J Swannell; N Williamson
Journal:  Ann Rheum Dis       Date:  1981-04       Impact factor: 19.103

10.  Enzyme replacement therapy for murine hypophosphatasia.

Authors:  José Luis Millán; Sonoko Narisawa; Isabelle Lemire; Thomas P Loisel; Guy Boileau; Pierre Leonard; Svetlana Gramatikova; Robert Terkeltaub; Nancy Pleshko Camacho; Marc D McKee; Philippe Crine; Michael P Whyte
Journal:  J Bone Miner Res       Date:  2008-06       Impact factor: 6.741

View more
  5 in total

Review 1.  [Hypophosphatasia : What is currently available for treatment?]

Authors:  T Schmidt; M Amling; F Barvencik
Journal:  Internist (Berl)       Date:  2016-12       Impact factor: 0.743

Review 2.  Proposing a clinical algorithm for better diagnosis of hypophosphatasia in resource-limiting situations.

Authors:  Sreyanko Sadhukhan; Poonam Mehta; Singh Rajender; Sushil Kumar Gupta; Naibedya Chattopadhyay
Journal:  Osteoporos Int       Date:  2022-07-01       Impact factor: 4.507

3.  Multiple fractures, pain, and severe disability in a patient with adult-onset hypophosphatasia.

Authors:  Neil A Braunstein
Journal:  Bone Rep       Date:  2015-10-30

Review 4.  Hypophosphatasia.

Authors:  Symeon Tournis; Maria P Yavropoulou; Stergios A Polyzos; Artemis Doulgeraki
Journal:  J Clin Med       Date:  2021-12-01       Impact factor: 4.241

5.  Gene Therapy Using Adeno-Associated Virus Serotype 8 Encoding TNAP-D10 Improves the Skeletal and Dentoalveolar Phenotypes in Alpl-/- Mice.

Authors:  Yuka Kinoshita; Fatma F Mohamed; Flavia Amadeu de Oliveira; Sonoko Narisawa; Koichi Miyake; Brian L Foster; José Luis Millán
Journal:  J Bone Miner Res       Date:  2021-06-15       Impact factor: 6.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.